Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 450 of 3173 entries
View as:

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT02184416 Org: User:
Start: 10/31/14 End: 09/30/22 Due: 09/30/23

A Study to Compare Two Ways of Completing Pain and Sleep Questions and to Evaluate a New Daily Questionaire for Assessing Fatigue in Fibromyalgia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00819624 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Phase: N/A Priority: Normal
NCT ID: NCT02680847 Org: User:
Start: 01/21/16 End: 01/24/18 Due: 01/24/19

A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT00763204 Org: User:
Start: 02/29/08 End: 03/07/08 Due: 03/07/09

Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00137436 Org: User:
Start: 10/31/05 End: 03/31/10 Due: 03/31/11

Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

Phase: N/A Priority: Normal
NCT ID: NCT00678106 Org: User:
Start: 09/30/08 End: 07/31/09 Due: 07/31/10

Use Of Fragmin In Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01879618 Org: User:
Start: 10/31/13 End: 03/31/16 Due: 03/31/17

A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05189639 Org: User:
Start: 12/05/23 End: 11/17/27 Due: 11/17/28

A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

Phase: N/A Priority: Normal
NCT ID: NCT03170609 Org: User:
Start: 06/05/17 End: 06/25/18 Due: 06/25/19

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Phase: N/A Priority: Normal
NCT ID: NCT01561469 Org: User:
Start: 11/30/08 End: 06/30/13 Due: 06/30/14

STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS

Phase: N/A Priority: Normal
NCT ID: NCT04756531 Org: User:
Start: 02/11/21 End: 09/01/21 Due: 09/01/22

Open-label Extension Study Of RN624

Phase: N/A Priority: Normal
NCT ID: NCT00399490 Org: User:
Start: 09/15/06 End: 02/11/08 Due: 02/11/09

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Phase: N/A Priority: Normal
NCT ID: NCT00683332 Org: User:
Start: 04/30/07 End: 05/31/10 Due: 05/31/11

A Study Of PF-05175157 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01274663 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Phase: N/A Priority: Normal
NCT ID: NCT05748171 Org: User:
Start: 05/17/23 End: 11/04/36 Due: 11/04/37

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

Phase: N/A Priority: Normal
NCT ID: NCT06678555 Org: User:
Start: 06/30/25 End: 12/31/25 Due: 12/31/26

An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00791492 Org: User:
Start: 07/31/08 End: 10/31/10 Due: 10/31/11

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT00649415 Org: User:
Start: 01/31/03 End: 07/31/03 Due: 07/31/04

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Phase: N/A Priority: Normal
NCT ID: NCT00174226 Org: User:
Start: 11/30/04 End: 01/31/06 Due: 01/31/07

A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

Phase: N/A Priority: Normal
NCT ID: NCT01466517 Org: User:
Start: 11/30/11 End: 11/30/11 Due: 11/30/12

PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02492984 Org: User:
Start: 04/30/15 End: 08/31/16 Due: 08/31/17

A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT06369454 Org: User:
Start: 05/03/24 End: 07/31/24 Due: 07/31/25

Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01164579 Org: User:
Start: 10/31/10 End: 11/30/13 Due: 11/30/14

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

Phase: N/A Priority: Normal
NCT ID: NCT01073605 Org: User:
Start: 07/31/93 End: 05/31/09 Due: 05/31/10

A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Phase: N/A Priority: Normal
NCT ID: NCT01557244 Org: User:
Start: 07/02/12 End: 02/13/20 Due: 02/13/21